Capital Wealth Planning’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2M Sell
125,419
-38,126
-23% -$5.84M 0.11% 60
2025
Q4
$22.7M Buy
163,545
+44,640
+38% +$5.85M 0.15% 37
2025
Q3
$15.2M Buy
118,905
+28,520
+32% +$3.48M 0.11% 37
2025
Q2
$10.9M Buy
90,385
+38,925
+76% +$4.39M 0.09% 34
2025
Q1
$5.74M Buy
51,460
+12,870
+33% +$1.37M 0.05% 40
2024
Q4
$3.76M Buy
38,590
+3,120
+9% +$333K 0.03% 53
2024
Q3
$4.08M Buy
35,470
+11,607
+49% +$1.32M 0.04% 46
2024
Q2
$2.54M Buy
23,863
+3,839
+19% +$385K 0.03% 66
2024
Q1
$1.94M Buy
20,024
+4,088
+26% +$419K 0.02% 67
2023
Q4
$1.61M Buy
15,936
+5,142
+48% +$496K 0.02% 68
2023
Q3
$1.1M Buy
10,794
+5,301
+97% +$538K 0.01% 57
2023
Q2
$554K Buy
5,493
+1,896
+53% +$190K 0.01% 87
2023
Q1
$331K Buy
+3,597
New +$314K ﹤0.01% 116

Other funds holding NVS